LSTA

Lisata Therapeutics (LSTA)

About Lisata Therapeutics (LSTA)

Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.

Details

Daily high

$3.21

Daily low

$3.15

Price at open

$3.20

52 Week High

$5.07

52 Week Low

$1.81

Market cap

28.7M

Dividend yield

0.00%

Volume

19,847

Avg. volume

100,599

P/E ratio

-1.65

Lisata Therapeutics News